Inspira Technologies OXY B.H.N. Ltd. has expanded its U.S. commercial footprint by deploying its FDA-cleared INSPIRA ART100 life-support system at a new premier New York academic medical center ranked among the state’s top 10 hospitals. The system has been integrated into clinical workflow for a structured commercial evaluation aimed at defining protocols and supporting potential broader adoption.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inspira Technologies OXY BHN Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: GNW9656666-en) on February 18, 2026, and is solely responsible for the information contained therein.